The pharmacy market - Spain

The global pharmacy market has witnessed significant growth, particularly influenced by COVID-19 and the rise in emerging markets. In 2021, the market experienced a sharp increase exceeding $1,400 billion, largely driven by COVID vaccine sales, especially in Europe and North America. The United States persists as the dominant player, encompassing 40.8% of global sales, while Western Europe and China follow with 14.7% and 11.9%, respectively. Pharmaceutical spending continues to expand, with an increase of 7.79% from 2020 to 2021, reaching about $1,493 billion.

Spanish pharmacies demonstrate growth trends, with medicine sales ascending to 10.7 billion euros in 2021 and the healthcare system reimbursements for pharmacy prescriptions reaching 11.7 billion euros. The Spanish market shows a high concentration of pharmacies, with 22,198 establishments in 2021, and an escalating demand with 1,023 million prescriptions dispensed in 2021. Online pharmacies in Spain are gaining traction, generating 296 million euros in 2021, with personal care products leading sales.

Pharmaceutical Market Dynamics and Consumer Trends in Spain

Spain's pharmaceutical market has been exhibiting a significant uptrend, mirroring the increasing necessity for medications and healthcare products, particularly against the backdrop of an aging population. The demand for pharmaceuticals is evident, with a palpable surge in the number of prescriptions dispensed at pharmacies, illustrating a growing dependency on such products. Between 2013 and 2021, Spanish pharmacies have seen an escalation in dispensed prescriptions, ascending from a ballpark of 850 million to over 1000 million. Equally, the spending patterns reflect the burgeoning market size. Spanish healthcare system reimbursed prescriptions have swelled sharply. The boost in spending on pharmaceuticals aligns with the global uptick, with worldwide spending rising by approximately 7 to 10 percent in just one year. The Spanish market has gravitated towards nervous system medications, digestive system drugs, and cardiovascular medicines as principal sales drivers, together constituting more than half of all pharmaceutical sales. This skew hints at prevalent health concerns amongst Spaniards and potential areas of focus for pharmaceutical endeavors. Geographically, regions like Extremadura and the Principality of Asturias lead in per capita pharmaceutical spending, whilst Madrid and Catalonia exhibit lower public expenditure, ranging from about 190 to over 300 euros per inhabitant.

The parapharmaceutical market, although broad and challenging to encapsulate, is another flourishing segment in Spain. Estimates suggest a valuation of around 5 billion euros. Beauty and skincare products, as a subset, boast a robust consumer base with millions engaging in the regular purchase of varying product types. The consumer profile for pharmacies skews towards a female demographic, predominantly active and middle-income brackets, with an average age of 45. While pharmacies remain the paramount channel for purchases, consumers are gradually indulging in multi-channel buying behaviors. This shift has been significantly catalyzed by the internet, with at least one-fourth of Spaniards seeking online information or purchasing beauty and skincare products. In the grand landscape of the Spanish pharmaceutical market, macro-trends suggest a swiftly evolving ecosystem. Aging demographics, heightened healthcare spending, increased prescription dispensing, and burgeoning multichannel consumer behaviors point towards a market ripe with opportunities for both established players and emergent startups alike. The call for strategic adaptation, digital transformation, and customer-centric service innovations rings louder than ever for stakeholders looking to capture value in this expanding industry.

Key Players Shaping the Pharmaceutical and Pharmacy Landscape in Spain

The Spanish pharmaceutical and pharmacy market is a vibrant and dynamic field with numerous key players that actively shape its landscape. Among the notable companies, several stand out due to their significant influence within the industry.

• Sanofi is a global giant in the pharmaceutical industry, known for its broad range of medicines and vaccines. Sanofi's presence in Spain underscores its commitment to delivering healthcare solutions that cater to a spectrum of medical needs.
• Novartis is another titan in the global pharmaceutical sector, with an expansive portfolio that includes cutting-edge treatments and therapies. Its operations in Spain reflect its global strategy of innovation and healthcare improvement.
• Pfizer has established itself as one of the most recognized names in pharmaceuticals worldwide. With a strong foothold in Spain, Pfizer has been instrumental in driving pharmaceutical advancements and improving patient outcomes.
• Johnson & Johnson, renowned for its diverse healthcare products, continues to make a substantial impact in Spain through its pharmaceutical division, offering innovative and trusted treatments.
• Roche is synonymous with pioneering healthcare solutions. In Spain, Roche's contribution to the pharmaceutical sector is marked by its commitment to research and development, striving to improve the lives of patients.
• On the pharmacy group front, Sanifarma, Redfarma, Farmactiva, Farmacias Trébol, Farmàcies Ecoceutic, and XarxaFarma are among the main Spanish pharmacy groups that play a pivotal role in the distribution of pharmaceuticals in Spain. They represent a significant part of the pharmacy network, providing the public with access to essential medicines and healthcare services.
• In terms of drug manufacturing, Instituto Grifols is a major player specializing in pharmaceuticals derived from plasma, while Bioibérica focuses on the production of biomolecules for pharmaceutical and nutraceutical purposes.
• When it comes to pharmaceutical wholesalers and laboratories, companies like Cofares, Bidafarm, and Alliance Healthcare are key distributors ensuring the supply of medications across the nation. They act as crucial intermediaries between manufacturers and pharmacies, maintaining the efficiency of Spain's pharmaceutical distribution chain.
• Evolving within the digital space, LUDA Partners represents a new generation of startups aiming to bridge the gap between pharmacies and the digital realm. By creating networks that facilitate medicine location and online sales, this innovative company reflects the burgeoning digital transformation within the pharmaceutical sector.

Inforamtion

• Number of pages : ~ 40 pages
• Format : Digital and PDF versions
• Last update : 23/05/2023

Summary and extracts